Alnylam Pharmaceuticals
ALNY
#730
Rank
A$48.31 B
Marketcap
A$361.11
Share price
-0.89%
Change (1 day)
-46.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company